{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-056939","form_type":"8-K","ticker":"NTRB","cik":"0001676047","company_name":"NutriBand Inc.","filed_at":"2023-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.822001+00:00","generated_at":"2026-06-13T08:14:11.711213+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nutriband replaces $2M credit line with $5M facility at 7% for AVERSA Fentanyl","bullets":["Secured $5M credit line at 7% interest, maturing July 13, 2026, replacing prior $2M facility.","Funds for AVERSA™ Fentanyl FDA approval and commercial manufacturing via Kindeva Drug Delivery.","No conversion rights; advances contingent on starting Kindeva work related to NDA filing.","Interest payable annually each Dec 31 starting 2023; prepayment allowed without penalty."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-056939","json":"https://secwatch.observer/filing/0001213900-23-056939.json","markdown":"https://secwatch.observer/filing/0001213900-23-056939.md","text":"https://secwatch.observer/filing/0001213900-23-056939.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676047/000121390023056939/0001213900-23-056939-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676047/000121390023056939/ea181821-8k_nutriband.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T08:14:11.711213+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ec4d213e6e4abc6006b3d0f543e7a51d5ce4cadb","claim":"NutriBand Inc. amended a credit facility valued at $5,000,000 (effective 2023-07-13).","evidence_excerpt":"The Company on July 13, 2023 entered into an amended three-year $5,000,000 credit line facility (replacing the $2,000,000 facility that we had entered into on March 19, 2023), drawdowns under which bear interest at the rate of 7% per annum.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676047/000121390023056939/0001213900-23-056939-index.htm","confidence":1.0,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Value","value":"$5,000,000"},{"label":"Effective","value":"2023-07-13"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}